stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Gratuito - Play StoreApp Store
InstallareInstallare
logo
Latigo Biotherapeutics, Inc. Common StockLTGO
$13.513.15%-0.44

Latigo Biotherapeutics, Inc. Common Stock (LTGO)

Date: 2026-11-02 16:00O: 14.03H: 15.02L: 13.26C: 13.51Vol: 290.1k
Precedente Chiudi:
$13.95
Aprire:
$14.03
Volume 24 ore:
290,064
Volume relativo:
1.66
Capitalizzazione di mercato:
$895.70M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1W Prestazione:
-11.18%
1M Prestazione:
-15.03%
6M Prestazione:
0.00%
1Y Prestazione:
0.00%
Intervallo 1D:
$0.00$0.00
Intervallo di 1 settimana:
$13.26$16.74
Portata 52W:
$13.26$25.93

Profilo aziendale di Latigo Biotherapeutics, Inc. Common Stock (LTGO)

Nome
Latigo Biotherapeutics, Inc. Common Stock
Settore
Healthcare
Industria
Biotechnology
Telefono
-
Indirizzo
USA
Dipendente
-
X
-
Prossima data di guadagno
2026-12-03
Ultimi documenti SEC
SEC
Discussioni di LTGO su X
X

 

Cap. di mercato

 

Reddito

 

Reddito netto

 

Flusso di cassa

 

EPS

 

Latigo Biotherapeutics, Inc. Common Stock Azioni (LTGO) Upgrade e downgrade

DataAzioneAnalistaModifica della valutazione
2026-09-01IniziatoGoldmanBuy
2026-09-01IniziatoGuggenheimBuy
2026-09-01IniziatoJefferiesBuy
2026-09-01IniziatoLeerink PartnersOutperform

Latigo Biotherapeutics, Inc. Common Stock Azioni (LTGO) Dati Finanziari

Non sono disponibili dati finanziari per Latigo Biotherapeutics, Inc. Common Stock (LTGO). Controlla altri titoli per ulteriori informazioni.

Latigo Biotherapeutics, Inc. Common Stock Azioni (LTGO) insider trading

  • Director
    Transazione
    Buy
    Costo
    $18.00
    #Azioni
    140,000
    Valore ($)
    2,520,000
    #Azioni Totale
    2,008,024
  • 10% Owner
    Transazione
    Buy
    Costo
    $18.00
    #Azioni
    140,000
    Valore ($)
    2,520,000
    #Azioni Totale
    2,008,024
Commercio internoRelazioneDataTransazioneCosto#AzioniValore ($)#Azioni Totale
Tananbaum James B.DirectorAug 10 '26Buy$18.00140,0002,520,0002,008,024
Foresite Capital Management V,10% OwnerAug 10 '26Buy$18.00140,0002,520,0002,008,024

Latigo Biotherapeutics, Inc. Common Stock Borsa (LTGO) Ultime notizie

Oct 29, 2026
Oct 29, 2026
Oct 21, 2026
Oct 21, 2026
Oct 15, 2026
Oct 15, 2026
Oct 01, 2026
Oct 01, 2026
Sep 28, 2026
Sep 28, 2026
Sep 28, 2026
Sep 28, 2026
Sep 24, 2026
Sep 24, 2026
Sep 03, 2026
Sep 03, 2026
Sep 01, 2026
Sep 01, 2026
Aug 13, 2026
Aug 13, 2026
Aug 12, 2026
Aug 12, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 09, 2026
Aug 09, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 04, 2026
Aug 04, 2026
Aug 04, 2026
Aug 04, 2026
Aug 04, 2026
Aug 04, 2026
Aug 04, 2026
Aug 04, 2026
Aug 03, 2026
Aug 03, 2026
Aug 03, 2026
Aug 03, 2026
Jul 28, 2026
Jul 28, 2026
Jul 20, 2026
Jul 20, 2026
Jul 17, 2026
Jul 17, 2026

Simile a LTGO